Article
AstraZeneca's Tagrisso-chemo combo results raise bar for J&J cancer drug-analysts
Rating:
0.0
Views:
67
Likes:
1
Library:
1
Data released on Monday by AstraZeneca from a late-stage trial combining its blockbuster cancer drug Tagrisso with chemotherapy to treat a type of lung cancer raises the bar for Johnson & Johnson's rival treatment, analysts said.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value